Literature DB >> 33079837

Pain, Depression, and Posttraumatic Stress Disorder Following Major Extremity Trauma Among United States Military Serving in Iraq and Afghanistan: Results From the Military Extremity Trauma and Amputation/Limb Salvage Study.

Renan C Castillo1, Anthony R Carlini1, William C Doukas2, Roman A Hayda3, Harold M Frisch4, Romney C Andersen5,6, Jean-Claude D'Alleyrand5,7, Michael T Mazurek1,2,3,4,5,6,7,8, James R Ficke8, John J Keeling5, Paul F Pasquina5, Harold J Wain5, Ellen J MacKenzie1.   

Abstract

OBJECTIVES: Assess the burden and co-occurrence of pain, depression, and posttraumatic stress disorder (PTSD) among service members who sustained a major limb injury, and examine whether these conditions are associated with functional outcomes.
DESIGN: A retrospective cohort study.
SETTING: Four U.S. military treatment facilities: Walter Reed Army Medical Center, National Naval Medical Center, Brooke Army Medical Center, and Naval Medical Center San Diego. PATIENTS/PARTICIPANTS: Four hundred twenty-nine United States service members who sustained a major limb injury while serving in Afghanistan or Iraq met eligibility criteria upon review of their medical records. INTERVENTION: Not applicable. MAIN OUTCOME MEASUREMENTS: Outcomes assessed were: function using the short musculoskeletal functional assessment; PTSD using the PTSD Checklist and diagnostic and statistical manual criteria; pain using the chronic pain grade scale.
RESULTS: Military extremity trauma and amputation/limb salvage patients without pain, depression, or PTSD, were, on average, about one minimally clinically important difference (MCID) from age- and gender-adjusted population norms. In contrast, patients with low levels of pain and no depression or PTSD were, on average, one to 2 MCIDs from population norms. Military extremity trauma and amputation/limb salvage patients with either greater levels of pain, and who experience PTSD, depression, or both, were 4 to 6 MCIDs from population norms. Regression analyses adjusting for injury type (upper or lower limb, salvage or amputation, and unilateral or bilateral), age, time to interview, military rank, presence of a major upper limb injury, social support, presence of mild traumatic brain injury/concussion, and combat experiences showed that higher levels of pain, depression, and PTSD were associated with lower one-year functional outcomes.
CONCLUSIONS: Major limb trauma sustained in the military results in significant long-term pain and PTSD. Overall, the results are consistent with the hypothesis that pain, depression, and PTSD are associated with disability in this population. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33079837     DOI: 10.1097/BOT.0000000000001921

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  4 in total

1.  Elevated Kinesiophobia Is Associated With Reduced Recovery From Lower Extremity Musculoskeletal Injuries in Military and Civilian Cohorts.

Authors:  Ruth L Chimenti; Molly S Pacha; Natalie A Glass; Mathew Frazier; Amy O Bowles; Andrew D Valantine; Kristin R Archer; Jason M Wilken
Journal:  Phys Ther       Date:  2022-02-01

2.  DoD-VA Trauma Infection Research Collaboration.

Authors:  Jay McDonald; Stephen Y Liang; Ping Li; Laveta Stewart; David R Tribble
Journal:  Mil Med       Date:  2022-05-04       Impact factor: 1.563

3.  Video Messaging to Increase Vascularized Composite Allograft Donation Willingness in United States Military Veterans.

Authors:  James R Rodrigue; Jessica Shenkel; Matthew Boger; Bohdan Pomahac; Aaron Fleishman
Journal:  Transplant Direct       Date:  2022-09-16

4.  Relationship Between Post-Traumatic Stress Disorder Symptoms and Chronic Pain-Related Symptom Domains Among Military Active Duty Service Members.

Authors:  Hongjin Li; Diane M Flynn; Krista B Highland; Patricia K Barr; Dale J Langford; Ardith Z Doorenbos
Journal:  Pain Med       Date:  2021-12-11       Impact factor: 3.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.